T1	Participants 582 627	in patients with mixed dyslipidaemia and MetS
T2	Participants 662 744	patients with low-density lipoprotein cholesterol (LDL-C) > 160 and TG > 200â€ƒmg/dl
T3	Participants 952 975	only patients with MetS
